The heart attack diagnostics market is expected to reach USD 15.4 billion by 2024, according to a new report by Grand View Research, Inc. The heart attack diagnostics market is anticipated to witness a lucrative growth during the forecast period from2016 to 2024. From 2001 to 2011, age-standardized, heart attack incidence rates have significantly decreased worldwide. However, the overall risk factors and the disease burden remains large, thereby rendering the heart attack diagnostic sectors a profitable growth prospect. This growth is attributed to a majority of factors, such as high prevalence of coronary heart diseases, increased tobacco smoking, and obesity, enhanced adoption of unhealthy diet is resulting in a high cholesterol incidence in individuals, particularly in the rising geriatric population. However, the low Medicare reimbursement provided for the mobile cardiac outpatient telemetry electrocardiogram (ECG) and the progressively declining heart attack incidence rates are expected to hamper the market growth.
The heart attack diagnostics market has been classified by product into electrocardiogram, which measures the electrical activity of the heart; echocardiogram, a form of ultrasound test that provides images of the heart; blood tests that measure the expression of certain proteins in excess, such as troponin levels, and cardiac enzymes; and other diagnostic products. The ECG segment is expected to witness a significant growth rate in developing countries, owing to the technological advances coupled with increasing applications of ECG. Although, the increasing demand for cost effective, rapid blood tests such as troponin and Creatine Kinase MB Isoenzyme (CK-MB) is likely to acquire major market share in the near future. The key countries landscape included in the report are U.S., Canada, Germany, UK, China, India, Brazil, Mexico, South Africa, and Middle East. The Asia Pacific region is anticipated to be the fastest growing region during the forecast period. On the other hand, North America is estimated to dominate the global heart attack diagnostics market.
View summary of this report @ http://www.grandviewresearch.com/industry-analysis/heart-attack-diagnostics-market
Further key findings from the study suggest:
·
North America is estimated to dominate the
global heart attack diagnostics market. The increasing awareness about heart
attacks, its causative and risk factors, and enhanced uptake and acceptance of
technologically advanced diagnostics is expected to contribute to the market
growth.
·
The Asia Pacific region is expected to be the
fastest growing region during the forecast period. to The reason being the
considerably large burden of heart diseases in certain developing regions, such
as in India, where 2.4 million people die annually due to heart diseases. As a
result of the soaring incidences of heart diseases, an urgent requirement to
undertake awareness measures and incorporate advanced diagnostics is expected
to fuel the market growth.
·
The troponin blood test type is the largest
grossing segment and is expected to capture the largest share in 2015,
especially in developing countries including Brazil, China, and India. Its
applications as a cardiac monitoring device and its indispensable use as a
heart attack diagnostic tool will be a contributing factor supporting the
market growth. The industry comprises of several local as well as global
players. Some of the major players of this industry include Siemens Healthcare
GmbH, Schiller AG, GE Healthcare, and Hitachi Medical Systems.
Browse
more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research has segmented the heart attack diagnostics market on the
basis of product and region: Heart Attack Diagnostics Test Type Outlook (Revenue, USD Million, 2013 - 2024)
·
Electrocardiogram (ECG)
·
Blood tests
o
Troponin
o
CK-MB
o
Others
·
Others
Heart Attack Diagnostics Regional Outlook (Revenue, USD Million,
2013 - 2024)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
UK
·
Asia Pacific
o
China
o
India
·
Latin America
o
Brazil
o
Mexico
·
MEA
o
Middle East
o
South Africa
For press release of this report - http://www.grandviewresearch.com/press-release/global-heart-attack-diagnostics-market
About Grand View
Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
Contact:
Sherry
James
Corporate
Sales Specialist, U.S.A.
Grand
View Research, Inc.
United
States
Phone: 1-415-349-0058
Toll
Free: 1-888-202-9519
Email: sales@grandviewresearch.com
No comments:
Post a Comment